PLN 9.19
(-3.26%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 29.14 Million PLN | 41.3% |
2022 | 19.27 Million PLN | 198.37% |
2021 | 6.46 Million PLN | -45.51% |
2020 | 11.85 Million PLN | -30.92% |
2019 | 17.16 Million PLN | 134.39% |
2018 | 7.32 Million PLN | 479.0% |
2017 | 1.26 Million PLN | -17.28% |
2016 | 1.52 Million PLN | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | -640 Thousand PLN | -110.96% |
2024 Q1 | 4.34 Million PLN | -42.66% |
2023 Q3 | 5.66 Million PLN | -34.21% |
2023 Q4 | 7.57 Million PLN | 33.64% |
2023 Q1 | 5.38 Million PLN | 2.94% |
2023 Q2 | 8.61 Million PLN | 59.84% |
2023 FY | 27.23 Million PLN | 41.3% |
2022 Q2 | 4.52 Million PLN | 6.25% |
2022 Q4 | 5.23 Million PLN | -0.46% |
2022 FY | 19.27 Million PLN | 198.37% |
2022 Q1 | 4.25 Million PLN | 199.91% |
2022 Q3 | 5.25 Million PLN | 16.22% |
2021 Q1 | 3.06 Million PLN | -32.71% |
2021 FY | 6.46 Million PLN | -45.51% |
2021 Q3 | 4.13 Million PLN | 17.4% |
2021 Q4 | -4.26 Million PLN | -203.05% |
2021 Q2 | 3.52 Million PLN | 15.02% |
2020 Q4 | 4.55 Million PLN | 77.4% |
2020 FY | 11.85 Million PLN | -30.92% |
2020 Q2 | 2.53 Million PLN | -50.12% |
2020 Q3 | 2.56 Million PLN | 1.26% |
2020 Q1 | 5.07 Million PLN | -9.62% |
2019 Q2 | 4.23 Million PLN | 40.44% |
2019 Q1 | 3.01 Million PLN | 9.42% |
2019 FY | 17.16 Million PLN | 134.39% |
2019 Q4 | 5.62 Million PLN | 31.23% |
2019 Q3 | 4.28 Million PLN | 1.03% |
2018 Q3 | 1.92 Million PLN | 29.97% |
2018 FY | 7.32 Million PLN | 479.0% |
2018 Q1 | 1.16 Million PLN | 171.23% |
2018 Q2 | 1.47 Million PLN | 27.53% |
2018 Q4 | 2.75 Million PLN | 43.45% |
2017 Q3 | 173.26 Thousand PLN | 0.0% |
2017 FY | 1.26 Million PLN | -17.28% |
2017 Q4 | 427.75 Thousand PLN | 146.87% |
2016 FY | 1.52 Million PLN | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Bioceltix S.A. | 15.38 Million PLN | -89.434% |
BIOTON S.A. | 57.55 Million PLN | 49.366% |
Captor Therapeutics Spolka Akcyjna | 79.91 Million PLN | 63.532% |
Mabion S.A. | 59.52 Million PLN | 51.037% |
Molecure S.A. | 31.73 Million PLN | 8.151% |
NanoGroup S.A. | 7.82 Million PLN | -272.369% |
Pharmena S.A. | -32.76 Million PLN | 188.949% |
Poltreg S.A. | 15.47 Million PLN | -88.33% |
Ryvu Therapeutics S.A. | 4.73 Million PLN | -515.112% |
Synthaverse S.A. | 26.35 Million PLN | -10.587% |
Urteste S.A. | 5.96 Million PLN | -388.338% |